Search

Precocious puberty (<300 d of age) can be successfully induced in a majority of heifers with early weaning and continuous feeding of a high-concentrate diet. The objective of this experiment was to determine the relative effects of timing of feeding a high-concentrate diet on age at puberty in early-weaned heifers. Sixty crossbred Angus and Simmental heifer calves were weaned at 112 ± 2 d of age and 155 ± 3 kg of BW and were fed a receiving diet for 2 wk. Heifers were blocked by age and BW, and assigned randomly to receive a high-concentrate (60% corn; H) or control (30% corn; C) diet during phase 1 (mean age 126 to 196 d) and H or C during phase 2 (mean age 196 to 402 d), resulting in 4 treatments (HH, n = 15; HC, n = 15; CII, n = 15; and CC, n 15). Blood samples were collected weekly beginning at a mean age of 175 d and assayed for progesterone concentration to determine age at puberty. After 56 d on the experimental diets, BW of heifers fed the H diet during phase 1 were greater (P < 0.05) than those of heifers fed the C diet (mean age of 182 d; treatment × mean age, P < 0.01). After 70 d on the new diets (mean age of 266 d), heifers fed the H diet during phase 2 reached heavier BW (P < 0.05) than heifers fed the C diet, when compared within phase 1 diet groups (RH > HC; CH > CC). Body weights in HC and CH treatments differed from a mean age of 169 through 238 d, after which BW did not differ between these treatments. The ADG over the entire experimental period was greatest for the HR treatment (1.2 ± 0.04 kg/d; P < 0.05), followed by the HC and CR treatments (1.0 ± 0.03 and 1.0 ± 0.02 kg/d, respectively), which were not different, and the CC treatment gained the least (0.7 ± 0.04 kg/d; P < 0.05). Precocious puberty occurred in 67, 47, 47, and 20% of heifers in the HH, HC, CH, and CC treatments, respectively (HR > CC; P < 0.05). Mean age at puberty for the RH and HC treatments (271 ± 17 and 283 ± 17 d of age, respectively) was earlier (P < 0.05) than for the CC treatment (331 ± 11 d of age). Age at puberty in the CR treatment (304 ± 13 d of age) was intermediate to and not different from the other treatments. Heifers fed the H diet during phase 1 attained puberty earlier (P < 0.05) than heifers fed the C diet during phase 1. In conclusion, increasing dietary energy intake in early-weaned heifers, through feeding a high-concentrate diet from 126 to 196 d of age, decreased age at puberty regardless of the diet fed after 196 d of age. [ABSTRACT FROM AUTHOR]

Precocious puberty (<300 d of age) can be successfully induced in a majority of heifers with early weaning and continuous feeding of a high-concentrate diet. The objective of this experiment was to determine the relative effects of timing of feeding a high-concentrate diet on age at puberty in early-weaned heifers. Sixty crossbred Angus and Simmental heifer calves were weaned at 112 ± 2 d of age and 155 ± 3 kg of BW and were fed a receiving diet for 2 wk. Heifers were blocked by age and BW, and assigned randomly to receive a high-concentrate (60% corn; H) or control (30% corn; C) diet during phase 1 (mean age 126 to 196 d) and H or C during phase 2 (mean age 196 to 402 d), resulting in 4 treatments (HH, n = 15; HC, n = 15; CII, n = 15; and CC, n 15). Blood samples were collected weekly beginning at a mean age of 175 d and assayed for progesterone concentration to determine age at puberty. After 56 d on the experimental diets, BW of heifers fed the H diet during phase 1 were greater (P < 0.05) than those of heifers fed the C diet (mean age of 182 d; treatment × mean age, P < 0.01). After 70 d on the new diets (mean age of 266 d), heifers fed the H diet during phase 2 reached heavier BW (P < 0.05) than heifers fed the C diet, when compared within phase 1 diet groups (RH > HC; CH > CC). Body weights in HC and CH treatments differed from a mean age of 169 through 238 d, after which BW did not differ between these treatments. The ADG over the entire experimental period was greatest for the HR treatment (1.2 ± 0.04 kg/d; P < 0.05), followed by the HC and CR treatments (1.0 ± 0.03 and 1.0 ± 0.02 kg/d, respectively), which were not different, and the CC treatment gained the least (0.7 ± 0.04 kg/d; P < 0.05). Precocious puberty occurred in 67, 47, 47, and 20% of heifers in the HH, HC, CH, and CC treatments, respectively (HR > CC; P < 0.05). Mean age at puberty for the RH and HC treatments (271 ± 17 and 283 ± 17 d of age, respectively) was earlier (P < 0.05) than for the CC treatment (331 ± 11 d of age). Age at puberty in the CR treatment (304 ± 13 d of age) was intermediate to and not different from the other treatments. Heifers fed the H diet during phase 1 attained puberty earlier (P < 0.05) than heifers fed the C diet during phase 1. In conclusion, increasing dietary energy intake in early-weaned heifers, through feeding a high-concentrate diet from 126 to 196 d of age, decreased age at puberty regardless of the diet fed after 196 d of age. [ABSTRACT FROM AUTHOR]

We have previously reported similar reproductive performance in GnRH-based programs when the interval from the initial GnRH injection to CIDR withdrawal and PGF2α (PGF) was reduced from 7 to 5 d and two PGF doses were given 12 h apart. In order to determine the efficacy of a single PGF injection at CIDR withdrawal in a 5 d program, two experiments were conducted to compare reproductive performance between a 7 d (7SS) or 5 d (5SS) Select Synch + CIDR program. Lactating beef cows (n = 137; Expt 1) and yearling heifers (n = 159; Expt 2) received the 7SS or 5SS program with a single PGF. In cows, estrus response was greater (P < 0.05) in the 7SS (98.5%) than 5SS (89.9%) treatment. Treatment by status (cyclic, anestrous; P < 0.05) and age (2 yr-old, mature; P < 0.05) interactions implied that cyclic and mature cows benefited from the 7SS treatment, whereas the 5SS treatment favored the anestrous and 2 yr-old cows. In heifers (Expt 2), estrus response (92.5%) and pregnancy rates (59.7%) were similar between treatments. In a third experiment (n = 216; Expt 3), reproductive performance was compared for a 7 (7CO) and 5 (5CO) d CO-Synch + CIDR program in postpartum cows. Based upon results of Expt 1, two injections of PGF, 12 h apart, were used. In the 7CO treatment, timed AI, concurrent with GnRH, was performed at 60 h after the initial PGF, whereas this interval (proestrus) was extended to 72 h in the 5CO treatment. Timed-AI pregnancy rate was greater (P < 0.05) in the 5CO (80.0%) than 7CO (66.7%) treatment. In conclusion, it is questionable if decreasing the Select-Synch program to 5 d is advantageous in either cows or heifers if a single PGF is administered. Conversely, the modified CO-Synch + CIDR program increased timed-AI pregnancy rates in postpartum beef cows. The relative contributions of the shorter GnRH to PGF interval and the longer duration of proestrus to enhance fertility warrants further investigation. [ABSTRACT FROM AUTHOR]

Four experiments were conducted in postpartum beef cows to evaluate the influence of reducing the interval from GnRH to PGF(2alpha) from 7 to 5d in a Select-Synch + CIDR or CO-Synch + CIDR estrous synchronization program. In Expt 1, cows (n=156) were treated with either a 7 or 5d Select-Synch + CIDR program. A second PGF(2alpha) treatment was given to all cows in all experiments at 12h after the initial PGF(2alpha) (to ensure that luteolysis occurred with the 5d program). Estrous response, interval to estrus, conception rate, and first service AI pregnancy rates were similar between treatments. In Expt 2, cows (n=223) were treated with either a 7 or 5d CO-Synch + CIDR program, with timed-AI concomitant with GnRH at 60 h after PGF(2alpha). Timed-AI pregnancy rates were similar between treatments. In Expt 3 (n=223) and 4 (n=400) cows were treated with either a 7 or 5d CO-Synch + CIDR program with timed-AI concurrent with GnRH at either 60 h (7d) or 72 h (5d) after CIDR withdrawal. Timed-AI pregnancy rates were 13.3% (P<0.05; Expt 3) and 9.1% (P<0.05; Expt 4) greater for the 5 than 7d program. In conclusion, timed-AI pregnancy rates were improved with a 5d CO-Synch + CIDR program with timed-AI at 72 h after CIDR withdrawal, compared to a 7d CO-Synch + CIDR program with timed-AI at 60 h after CIDR withdrawal.

Changes in steroidogenic function and associated gene expression were characterized in dominant ovarian follicles (DF) of cattle where follicles were induced to become atretic by systemic administration of estradiol benzoate (EB). In experiment 1, follicular fluid (FF) steroid concentrations in the DF were measured at 12-hourly time points for 48 h in heifers treated with 1 mg EB i.m./500 kg body weight (EB; n=20) as compared with untreated controls (C; n=19). Treatment with EB promoted a transient reduction in circulating FSH, a rapid (12 h) and sustained reduction in FF estradiol, a rapid (12 h) but transient reduction in FF progesterone and a delayed (36 h) increase in FF testosterone concentrations. In experiment 2, whole follicular wall tissue was collected from DF of mature non-lactating cows allocated to a 0 h control group (0 HC: n=7), a 24h control group (24 HC; n=7) or an EB-treated group where tissue was collected 24 h after administration of 1 mg EB i.m./500 kg body weight (EB; n=8). As for experiment 1, EB promoted a transient reduction in circulating FSH, a pronounced reduction in FF estradiol and a smaller but significant reduction in FF progesterone concentrations. Semi-quantitative RT-PCR on follicular wall tissue revealed that the loss in estrogen activity at 24 h after EB was associated with two-fold reduction in aromatase mRNA, with an apparent acceleration in loss of 17alpha-hydroxylase mRNA. Expression of genes for gonadotropin receptors (LHR and FSHR) and a cell-death signalling pathway (Fas antigen and Fas ligand) were unchanged during the initial 24h of EB-induced atresia. These results suggest that EB initiates atresia in dominant ovarian follicles through a rapid suppression of follicular estradiol synthesis, an effect associated with down-regulation of the aromatase gene. A transient suppression in circulating FSH following administration of EB appears to have initiated these events, and it is suggested that subsequent processes involved in atresia follow this loss in estrogenic function.

Administration of estradiol benzoate (EB) induces atresia of the dominant follicle (DF) in the ovaries of cattle within 36 h but emergence of a new wave of follicular development is delayed by 3-5 days. The present study investigated the role of EB in determining timing of emergence of a new follicular wave after removing the influence of the DF. At 6.4+/-0.2 days after ovulation in Angus and Angus/Simmental cattle (n=26), aged 4.9+/-0.6 years and weighing 634+/-20 kg, all ovarian follicles > or =5mm in diameter were aspirated with a 17-gauge needle using an ultrasound-guided transvaginal approach (Day 0 or Hour 0) and animals immediately received 0 (0EB), 1 (1EB), 2 (2EB) or 4 (4EB) mg EB i.m./500 kg body weight (n=6 or 7 per treatment). Ovarian structures were monitored by ultrasonography on a daily basis until emergence of a new wave of follicular development. Concentrations of estradiol (E2) were different among all treatments between Hours 24 and 72, increasing (P<0.01) with greater doses of EB administered. Hour of peak follicle-stimulating hormone (FSH) was 29.3+/-4.0, 53.3+/-4.5, 81.1+/-15.5, and 91.4+/-8.2 for the 0EB, 1EB, 2EB, and 4EB treatments, respectively, and emergence of a new wave of follicular development occurred on Days 1.5+/-0.2, 3.3+/-0.3, 4.0+/-0.6 and 4.4+/-0.4, respectively. Timing of peak FSH and emergence of a new wave of follicular development was earliest (P<0.05) in the 0EB treatment, similar (P>0.1) among the 1EB and 2EB treatments, and most delayed (P<0.05) in the 4EB treatment when compared to the 0EB or 1EB treatments. The overall mean interval from peak FSH to emergence of a new wave of follicular development was 15.7+/-3.3 h and was not affected by treatment. Concentrations of E2 at 24 h before new emergence were not different among EB-treated animals (20.2+/-5.5 pg/ml), but lower (P<0.01) in the 0EB treatment (1.6+/-0.2 pg/ml). In a dose-dependent manner, EB delayed the pre-emergence surge in FSH that stimulates new follicular development after the DF has ceased to be functional. The importance of using an 'optimal' dose of EB in hormonal regimens using this agent to strategically regulate follicular development is emphasized by the outcomes of this study.